Susan Moench

Immune checkpoint inhibitor therapy and risk of TB exacerbation

Immune checkpoint therapy with programmed cell death-1 (PD-1) inhibitors was linked to activation of latent Mycobacterium tuberculosis (Mtb) infection in 2 patients, according to a case study report published in Science Translational Medicine.  

Read More →

Page 1 of 1 · Total posts: 1